Market Overview

BofA Moves To Sidelines On BWX Technologies, Says Growth Is Already Priced In

Share:
BofA Moves To Sidelines On BWX Technologies, Says Growth Is Already Priced In

Shares of BWX Technologies Inc (NYSE: BWXT), a leading supplier of nuclear components and fuel to the U.S. government, are valued to the company's potential, according to Bank of America Merrill Lynch.

The Analyst

Analyst Ronald Epstein downgraded BWX from Buy to Neutral and maintained a $70 price target.

The Thesis

The two key growth themes for BWX are the prospects in U.S. Navy submarine and aircraft carrier procurement and potential long-term upside from its investment in medical radioisotopes, Epstein said in a Thursday note. (See the analyst's track record here.) 

The near- and medium-term growth from the two sectors is already priced into BWX stock, the analyst said. 

The U.S. Navy's plan to produce three Virginia-class submarines per year, from two per year, presents a $2-billion revenue opportunity over the next 15-20 years, Epstein said. 

The analyst projects the upside will result in as much as $501 million net present value, or $5 per share in valuation.

BofA values the company's medical isotope business at $5 per share, with the valuation assuming average annual revenues in the range of $100 million to $500 million and margins of 10-25 percent.

"A fourth Virginia-class submarine per year or better-than-expected success from BWXT's entrance into the medical radioisotope business could provide upside to our valuation," Epstein said. 

With BWX expecting revenues from the medical radioisotope business to kick in only after 2019, Epstein said significant upside from its estimated valuation is unlikely in the near term.

The Price Action

BWX shares have gained about 13 percent year-to-date.

Related Links:

Credit Suisse: Pension Income, Potential Budget Slowdown Neutralize Defense Manufacturers

Height: Amazon Likely To Land $10B Defense Contract

Latest Ratings for BWXT

DateFirmActionFromTo
Nov 2018Initiates Coverage OnBuy
Nov 2018DowngradesBuyHold
Aug 2018MaintainsBuyBuy

View More Analyst Ratings for BWXT
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill Lynch Ronald EpsteinAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (BWXT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NEEMizuhoMaintains245.0
EMP.ABarclaysMaintains40.0
ORCLBarclaysMaintains60.0
CIENBarclaysMaintains56.0
WMBSunTrust Robinson HumphreyInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Top Upgrades, Downgrades For May 24, 2018

Morgan Stanley Revisits Auto OEMs, Says Fiat Chrysler Has 'Strategic Potential,' Ford 'Out Of Favor'